Literature DB >> 18769113

TGFbeta modulates PTEN expression independently of SMAD signaling for growth proliferation in colon cancer cells.

Jimmy Y C Chow1, Jennifer A Cabral, Jessica Chang, John M Carethers.   

Abstract

Signaling pathways enabling transforming growth factor-beta (TGFbeta)'s conversion from a tumor suppressor to a tumor promoter are not well characterized. TGFbeta utilizes intracellular SMADs to mediate growth suppression; however, TGFbeta-induced proliferative pathways may become more apparent when SMAD signaling is abrogated. Here, we determined regulation of the tumor suppressor PTEN by TGFbeta utilizing SMAD4-null colon cancer cells. TGFbeta downregulated PTEN mRNA and simultaneously induced growth proliferation. TGFbeta also induced both SMAD2 and SMAD3 nuclear translocation, but only triggered SMAD2-specific transcriptional activity in the absence of SMAD4. Interference of SMAD2 with DN-SMAD2 enhanced TGFbeta-induced cell proliferation, but downregulation of PTEN expression by TGFbeta was unaffected. TGFbeta increased PI3K tyrosine phosphorylation, and inhibition of PI3K pharmacologically or by DN-p85 transfection reversed both TGFbeta-induced PTEN suppression and TGFbeta-induced cell proliferation. Thus, TGFbeta activates PI3K to downregulate PTEN for enhancement of cell proliferation that is independent of SMAD proteins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18769113      PMCID: PMC2820113          DOI: 10.4161/cbt.7.10.6665

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  42 in total

Review 1.  The multiple roles of PTEN in tumor suppression.

Authors:  A Di Cristofano; P P Pandolfi
Journal:  Cell       Date:  2000-02-18       Impact factor: 41.582

2.  Genetic heterogeneity in familial juvenile polyposis.

Authors:  S C Huang; C R Chen; J E Lavine; S F Taylor; R O Newbury; T T Pham; L Ricciardiello; J M Carethers
Journal:  Cancer Res       Date:  2000-12-15       Impact factor: 12.701

3.  Nuclear localization of Dpc4 (Madh4, Smad4) in colorectal carcinomas and relation to mismatch repair/transforming growth factor-beta receptor defects.

Authors:  E Montgomery; M Goggins; S Zhou; P Argani; R Wilentz; M Kaushal; S Booker; K Romans; P Bhargava; R Hruban; S Kern
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

Review 4.  PTEN: life as a tumor suppressor.

Authors:  L Simpson; R Parsons
Journal:  Exp Cell Res       Date:  2001-03-10       Impact factor: 3.905

5.  The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling.

Authors:  T Virolle; E D Adamson; V Baron; D Birle; D Mercola; T Mustelin; I de Belle
Journal:  Nat Cell Biol       Date:  2001-12       Impact factor: 28.824

6.  Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway.

Authors:  J Xu; L Attisano
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

Review 7.  Role of transforming growth factor beta in cancer.

Authors:  B Pasche
Journal:  J Cell Physiol       Date:  2001-02       Impact factor: 6.384

8.  TGF-beta mediates PTEN suppression and cell motility through calcium-dependent PKC-alpha activation in pancreatic cancer cells.

Authors:  Jimmy Y C Chow; Hui Dong; Khai T Quach; Phuoc Nam Van Nguyen; Kevin Chen; John M Carethers
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-01-31       Impact factor: 4.052

9.  Roles of autocrine TGF-beta receptor and Smad signaling in adipocyte differentiation.

Authors:  L Choy; J Skillington; R Derynck
Journal:  J Cell Biol       Date:  2000-05-01       Impact factor: 10.539

10.  Reduced PTEN expression in the pancreas overexpressing transforming growth factor-beta 1.

Authors:  M P A Ebert; G Fei; L Schandl; C Mawrin; K Dietzmann; P Herrera; H Friess; T M Gress; P Malfertheiner
Journal:  Br J Cancer       Date:  2002-01-21       Impact factor: 7.640

View more
  17 in total

1.  Signaling via Alk5 controls the ontogeny of lung Clara cells.

Authors:  Yiming Xing; Changgong Li; Aimin Li; Somyoth Sridurongrit; Caterina Tiozzo; Saverio Bellusci; Zea Borok; Vesa Kaartinen; Parviz Minoo
Journal:  Development       Date:  2010-03       Impact factor: 6.868

2.  Colon cancer stem cells.

Authors:  Feras J Abdul Khalek; G Ian Gallicano; Lopa Mishra
Journal:  Gastrointest Cancer Res       Date:  2010-11

3.  Transforming growth factor β-regulated microRNA-29a promotes angiogenesis through targeting the phosphatase and tensin homolog in endothelium.

Authors:  Jun Wang; Youliang Wang; Yu Wang; Ying Ma; Yu Lan; Xiao Yang
Journal:  J Biol Chem       Date:  2013-02-20       Impact factor: 5.157

4.  Secondary Prevention of Colorectal Cancer: Is There an Optimal Follow-up for Patients with Colorectal Cancer?

Authors:  John M Carethers
Journal:  Curr Colorectal Cancer Rep       Date:  2010-01-13

5.  Intersection of transforming growth factor-beta and Wnt signaling pathways in colorectal cancer and metastasis.

Authors:  John M Carethers
Journal:  Gastroenterology       Date:  2009-05-29       Impact factor: 22.682

6.  EMILIN1-α4/α9 integrin interaction inhibits dermal fibroblast and keratinocyte proliferation.

Authors:  Carla Danussi; Alessandra Petrucco; Bruna Wassermann; Eliana Pivetta; Teresa Maria Elisa Modica; Lisa Del Bel Belluz; Alfonso Colombatti; Paola Spessotto
Journal:  J Cell Biol       Date:  2011-09-26       Impact factor: 10.539

7.  Effects of activin and TGFβ on p21 in colon cancer.

Authors:  Jessica Bauer; Judith C Sporn; Jennifer Cabral; Jessica Gomez; Barbara Jung
Journal:  PLoS One       Date:  2012-06-26       Impact factor: 3.240

8.  Deregulation of selective autophagy during aging and pulmonary fibrosis: the role of TGFβ1.

Authors:  Meredith L Sosulski; Rafael Gongora; Svitlana Danchuk; Chunmin Dong; Fayong Luo; Cecilia G Sanchez
Journal:  Aging Cell       Date:  2015-06-09       Impact factor: 9.304

9.  A computational approach to identifying gene-microRNA modules in cancer.

Authors:  Daeyong Jin; Hyunju Lee
Journal:  PLoS Comput Biol       Date:  2015-01-22       Impact factor: 4.475

10.  microRNA 21: response to hormonal therapies and regulatory function in leiomyoma, transformed leiomyoma and leiomyosarcoma cells.

Authors:  Qun Pan; Xiaoping Luo; Nasser Chegini
Journal:  Mol Hum Reprod       Date:  2009-11-11       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.